Description
The DoW Prostate Cancer, Data Science Award supports research that develops or uses quantitative and analytical approaches, processes, and/or systems to obtain knowledge and insight from large and/or complex sets of prostate cancer data. The award mechanism allows for multiple Principal Investigators and encourages collaborations between data scientists and clinicians. The research should address one of the FY26 PCRP Overarching Challenges, which include improving overall health, wellness, and survivorship for those impacted by prostate cancer, developing new treatments or improving existing therapies, enhancing clinical care, and defining the biology of prostate cancer progression.
Some key aspects of the award include:
• The maximum period of performance is 3 years.
• The total costs budgeted for the entire period of performance should not exceed $1.4M.
• The award cannot support prospective recruitment of human subjects and/or clinical trials.
• The award encourages the development of resources or tools that allow research, clinical care, and patient community access to standardized and harmonized datasets for real-time clinical care applications.
• The award requires a data and resource sharing plan, which should describe how the data science tools, processes, and/or methods developed will be designed to accommodate integration of additional data from future studies.
Some of the key eligibility criteria include:
• Extramural and intramural U.S. Department of War organizations are eligible to apply.
• Independent investigators affiliated with an eligible organization are eligible to be named Principal Investigator.
• Cost sharing is not an eligibility requirement.